Catalyst Wire Dossier Catalyst Wire Dossier

Pyrimidine nucleosides (combination)

· UCB BIOSCIENCES, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pyrimidine nucleosides (combination), covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency [Phase 2]

See pricing